Zymeworks ZYME Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -140.4%-53.0pp | -87.3%-34.8pp | -52.5%+14.8pp | -67.3%+66.5pp | -133.8%+45.9pp | |
| Net margin | -126.3%-49.8pp | -76.6%-29.4pp | -47.2%+12.8pp | -60%+61.8pp | -121.7%+39.1pp | |
| EBITDA margin | -132.6%-52.6pp | -80%-34.7pp | -45.3%+13.8pp | -59.1%+64.5pp | -123.6%+44.7pp | |
| Free cash flow margin | -94.8%-62.2pp | -32.6%+16.1pp | -48.7%— | —— | —— | |
| Returns | ||||||
| Return on equity | -42%-15.3pp | -26.7%-8.3pp | -18.5%+1.4pp | -19.9%+9.9pp | -29.8%+0.7pp | |
| Return on assets | -22.7%-2.7pp | -20%-5.7pp | -14.3%+1.6pp | -15.9%+7.3pp | -23.2%+0.3pp | |
| Efficiency | ||||||
| Asset turnover | 0.2×-0.1× | 0.3×0.0× | 0.3×0.0× | 0.3×+0.1× | 0.2×0.0× | |
| Liquidity | ||||||
| Current ratio | 10.8×+4.9× | 5.9×-1.1× | 6.9×-0.8× | 7.7×+3.0× | 4.7×+1.3× | |
| Quick ratio | 10.8×+4.9× | 5.9×-1.1× | 6.9×-0.8× | 7.7×+3.0× | 4.7×+1.3× | |
| Cash ratio | 6.9×+5.9× | 1×-0.6× | 1.5×-1.0× | 2.6×+1.4× | 1.2×+0.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0×0.0× | 0.1×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Interest coverage | -9×-2.1× | -6.9×-2.0× | -4.9×+0.4× | -5.3×+1.9× | -7.2×-0.3× | |
| Per Share | ||||||
| Book value per share | $2.19-38.5% | $3.56-15.7% | $4.22-2.3% | $4.32+0.1% | $4.32-3.2% | |
| Valuation | ||||||
| Market capitalization | $1.86B-6.3% | $1.99B+53.5% | $1.29B+34.8% | $959.51M+15.8% | $828.66M-17.8% | |
| Enterprise value | $1.63B-16.8% | $1.96B+57.3% | $1.25B+41.8% | $879.93M+14.1% | $770.93M-19.8% | |
| Price / sales | 22.9×+4.2× | 18.7×+9.1× | 9.6×+1.8× | 7.8×-1.1× | 8.9×-4.3× | |
| Price / book | 11.4×+4.0× | 7.4×+3.4× | 4×+1.2× | 2.9×+0.3× | 2.6×-0.4× | |
| EV / sales | 20.1×+1.6× | 18.5×+9.2× | 9.3×+2.1× | 7.2×-1.1× | 8.3×-4.3× | |
| Free cash flow yield | -4.1%-2.4pp | -1.7%+3.3pp | -5.1%— | —— | —— | |
| Earnings yield | -5.5%-1.4pp | -4.1%+0.8pp | -4.9%+2.8pp | -7.7%+6.0pp | -13.7%-1.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Zymeworks's ratios come from?
- Every ratio is computed from Zymeworks's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.